Company History
Company strategy
Career
Licensed partners
Board of directors
Management team
About GERD
Patient story – Life with GERD
Patient Story - Everyday life with GERD
Linaprazan glurate
PPIs versus P-CABs
Development strategy
Clinical development
Corporate Governance Reports
General Meetings
2025
2024
2023
2022
The work of the board
Board committees
Management
Founders & Senior Advisors
Nomination Committee
Nomination committee instructions
Remuneration
Guidelines for remuneration
Remuneration reports
Auditing
Articles of Association
Internal control
The Share
Ownership structure
Dividend policy
Analyst coverage
Financial Reports
Annual Reports
Interim Reports
Press releases
Calendar
Presentations
Notice of EGM December 2022 (sv. kallelse)
Power of attorney form (sv. fullmaktsformulär)
Advance voting form (sv. förhandsröstningsformulär)
The Board of Director's Report, Swedish Companies Act 14:8 (sv. styrelseredogörelse ABL 14 kap 8 §)
Auditor's Statement, Swedish Companies Act 14:8 (sv. revisorsyttrande enligt ABL 14 kap 8 §)
Terms and Conditions for Cinclus Pharma Holding (publ)’s warrants under QESO 2022 (sv. Teckningsoptionsvillkor)